We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
TB SA Acquisition Corporation | NASDAQ:TBSAU | NASDAQ | Trust |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.18 | 9.64 | 2,147.48 | 0 | 01:00:00 |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
001-40260 |
/A | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
PO Box 1093, Boundary Hall Cricket Square Grand Cayman, |
KY 1-1102 | |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant to acquire one Class A ordinary share |
TBSAU |
The NASDAQ Stock Market LLC | ||
Class A ordinary shares included as part of the units |
TBSA |
The NASDAQ Stock Market LLC | ||
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share |
TBSAW |
The NASDAQ Stock Market LLC |
Large accelerated filer |
☐ |
Accelerated filer |
☐ | |||
Non-accelerated filer |
☒ |
Smaller reporting company |
☒ | |||
Emerging growth company | ☒ |
March 31, 2022 (Unaudited) |
December 31, 2021 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash |
$ | 213,240 | $ | 252,323 | ||||
Prepaid expenses |
585,940 | 555,000 | ||||||
|
|
|
|
|||||
Total current assets |
799,180 | 807,323 | ||||||
Cash held in Trust account |
200,034,831 | 200,014,773 | ||||||
Prepaid expenses, non-current |
— | 123,164 | ||||||
|
|
|
|
|||||
Total assets |
$ | 200,834,011 | $ | 200,945,260 | ||||
|
|
|
|
|||||
Liabilities and Shareholders’ Deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable and accrued expenses |
$ | 1,762,229 | $ | 1,582,505 | ||||
Working capital loan—related party |
256,000 | — | ||||||
Due to related party |
296,576 | 243,038 | ||||||
|
|
|
|
|||||
Total current liabilities |
2,314,805 | 1,825,543 | ||||||
Warrant liabilities |
2,640,000 | 5,610,000 | ||||||
|
|
|
|
|||||
Total liabilities |
4,954,805 | 7,435,543 | ||||||
|
|
|
|
|||||
Commitments and Contingencies (See Note 6) |
||||||||
Class A ordinary shares subject to possible redemption, 20,000,000 shares at redemption value of $10.00 per share |
200,034,831 | 200,014,773 | ||||||
Shareholders’ Deficit: |
||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding (excluding 20,000,000 shares subject to possible redemption) |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,000,000 shares issued and outstanding |
500 | 500 | ||||||
Additional paid-in capital |
554,300 | 267,150 | ||||||
Accumulated deficit |
(4,710,425 | ) | (6,772,706 | ) | ||||
|
|
|
|
|||||
Total shareholders’ deficit |
(4,155,625 | ) | (6,505,056 | ) | ||||
|
|
|
|
|||||
Total Liabilities and Shareholders’ Deficit |
$ | 200,834,011 | $ | 200,945,260 | ||||
|
|
|
|
For the three months ended March 31, 2022 |
For the period from January 27, 2021 (Inception) through March 31, 2021 |
|||||||
Formation and operating costs |
$ | 639,569 | $ | 40,802 | ||||
Stock compensation expense |
267,150 | 267,150 | ||||||
|
|
|
|
|||||
Loss from operations |
(906,719 | ) | (307,952 | ) | ||||
|
|
|
|
|||||
Other Income (Expense) |
||||||||
Interest income |
20,058 | — | ||||||
Offering expenses related to warrant issuance |
— | (233,453 | ) | |||||
Change in fair value of working capital loan—related party |
(1,000 | ) | — | |||||
Change in fair value of over-allotment liability |
— | (23,457 | ) | |||||
Change in fair value of warrant liabilities |
2,970,000 | 550,000 | ||||||
|
|
|
|
|||||
Total other income |
2,989,058 | 293,090 | ||||||
|
|
|
|
|||||
Net income (loss) |
$ | 2,082,339 | $ | (14,862 | ) | |||
|
|
|
|
|||||
Weighted average shares outstanding of Class A ordinary share |
20,000,000 | 2,187,500 | ||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class A ordinary share |
$ | 0.08 | $ | (0.00 | ) | |||
|
|
|
|
|||||
Weighted average shares outstanding of Class B ordinary share |
5,000,000 | 4,609,375 | ||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class B ordinary share |
$ | 0.08 | $ | (0.00 | ) | |||
|
|
|
|
Ordinary Shares |
Additional |
Total |
||||||||||||||||||||||||||
Class A |
Class B |
Paid-In |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance as of January 1, 2022 |
— |
$ |
— |
5,000,000 |
$ |
500 |
$ |
267,150 |
$ |
(6,772,706 |
) |
$ |
(6,505,056 |
) | ||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | — | — | — | — | (20,058 | ) | (20,058 | ) | |||||||||||||||||||
Proceeds received in excess of initial fair value of working capital loan—related party |
— | — | — | — | 20,000 | — | 20,000 | |||||||||||||||||||||
Fair value of Founder Shares transferred to Directors |
— | — | — | — | 267,150 | — | 267,150 | |||||||||||||||||||||
Net incom e |
— | — | — | — | — | 2,082,339 | 2,082,339 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of March 31, 2022 |
— |
$ |
— |
5,000,000 |
$ |
500 |
$ |
554,300 |
$ |
(4,710,425 |
) |
$ |
(4,155,625 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares |
Additional |
Total |
||||||||||||||||||||||||||
Class A |
Class B |
Paid-In |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance as of January 27, 2021 (Inception) |
— |
$ |
— |
— |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
||||||||||||||||
Issuance of Founder Shares |
— | — | 5,750,000 | 575 | 24,425 | — | 25,000 | |||||||||||||||||||||
Excess Sponsor paid over Fair value of Private Placement Warrants |
— | — | — | — | 563,334 | — | 563,334 | |||||||||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | — | — | — | (587,759 | ) | (13,094,838 | ) | (13,682,597 | ) | ||||||||||||||||||
Fair value of Founder Shares transferred to Directors |
— | — | — | — | 267,150 | — | 267,150 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (14,862 | ) | (14,862 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of March 31, 2021 |
— |
$ |
— |
5,750,000 |
$ |
575 |
$ |
267,150 |
$ |
(13,109,700 |
) |
$ |
(12,841,975 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended March 31, 2022 |
For the period from January 27, 2021 (Inception) through March 31, 2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | 2,082,339 | $ | (14,862 | ) | |||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Offering costs allocated to Warrants |
— | 233,453 | ||||||
Change in fair value of warrant liabilities |
(2,970,000 | ) | (550,000 | ) | ||||
Change in fair value of working capital loan—related party |
1,000 | — | ||||||
Change in fair value of over-allotment liabilities |
— | 23,457 | ||||||
Stock compensation expense |
267,150 | 267,150 | ||||||
Interest earned on Trust Account |
(20,058 | ) | — | |||||
Changes in current assets and current liabilities: |
||||||||
Prepaid assets |
92,224 | (1,111,665 | ) | |||||
Accounts payable and accrued expenses |
179,724 | 1,765,967 | ||||||
Due to related party |
53,538 | — | ||||||
Net cash (used in) provided by operating activities |
(314,083 |
) |
613,500 |
|||||
Cash Flows from Investing Activity: |
||||||||
Investment of cash into Trust Account |
— | (200,000,000 | ) | |||||
Net cash used in investing activity |
— | (200,000,000 |
) | |||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from Initial Public Offering, net of underwriter’s discount |
— | 196,000,000 | ||||||
Proceeds from purchase of Private Placement Warrants by related party |
— | 6,500,001 | ||||||
Proceeds from issuance of Working Capital Loan—related party |
275,000 | — | ||||||
Proceeds from issuance of Promissory note—related party |
— |
133,541 |
||||||
Proceeds from issuance of Founder Shares |
— | 25,000 | ||||||
Payment of offering costs |
— | (772,041 | ) | |||||
Net cash provided by financing activities |
275,000 |
201,886,501 |
||||||
Net Change in Cash |
(39,083 |
) |
2,500,001 |
|||||
Cash—Beginning |
252,323 | — | ||||||
Cash—Ending |
$ |
213,240 |
$ |
2,500,001 |
||||
Supplemental Disclosure of Non-Cash Financing Activity: |
||||||||
Proceeds received in excess of initial fair value of working capital loan—related party |
$ | 20,000 | $ | — | ||||
Remeasurement of Class A ordinary shares subject to possible redemption |
$ | 20,058 | $ | 13,682,597 | ||||
For the three months ended March 31, 2022 |
||||||||
Class A |
Class B |
|||||||
Basic and diluted net income per share: |
||||||||
Numerator: |
||||||||
Allocation of net income |
$ | 1,665,871 | $ | 416,468 | ||||
Denominator: |
||||||||
Weighted-average shares outstanding |
20,000,000 | 5,000,000 | ||||||
|
|
|
|
|||||
Basic and diluted net income per share |
$ | 0.08 | $ | 0.08 | ||||
|
|
|
|
For the period from January 27, 2021 (Inception) through March 31, 2021 |
||||||||
Class A |
Class B |
|||||||
Basic and diluted net loss per share: |
||||||||
Numerator: |
||||||||
Allocation of net loss |
$ | (4,783 | ) | $ | (10,079 | ) | ||
Denominator: |
||||||||
Weighted-average shares outstanding |
2,187,500 | 4,609,375 | ||||||
|
|
|
|
|||||
Basic and diluted net loss per share |
$ | (0.00 | ) | $ | (0.00 | ) | ||
|
|
|
|
Gross proceeds from IPO |
$ | 200,000,000 | ||
Less: |
||||
Proceeds allocated to Public Warrants |
(9,133,333 | ) | ||
Proceeds allocated to derivative liability |
(10,676 | ) | ||
Class A ordinary share issuance costs |
(4,538,588 | ) | ||
Plus: |
||||
Remeasurement adjustment of carrying value to redemption value |
13,697,370 | |||
Class A ordinary shares subject to possible redemption at December 31, 2021 |
200,014,773 | |||
Plus: |
||||
Remeasurement adjustment of carrying value to redemption value |
20,058 | |||
|
|
|||
Class A ordinary shares subject to possible redemption at March 31, 2022 |
$ | 200,034,831 | ||
|
|
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each Warrant holder; and |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders. |
• | in whole and not in part; |
• | at $ 0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table sets forth ender “Description of Securities—Warrants—Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of the Class A ordinary shares (as defined above) except as otherwise described below; and |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders. |
Number of Shares |
||||
Granted on March 12, 2021 |
195,000 | |||
Forfeited |
— | |||
Vested |
(48,750 | ) | ||
Unvested Outstanding at December 31, 2021 |
146,250 |
|||
Vested |
(48,750 |
) | ||
Unvested Outstanding at March 31, 2022 |
97,500 |
Amount Vested |
||||
Amount vested on March 22, 2021, the Company’s IPO date (represents 25% of shares vested or 48,750 shares) |
$ | 267,150 | ||
Amount |
267,150 | |||
Amount to be vested upon the Company’s consummation of a successful business combination (represents 50% of shares vested or 97,500 shares) |
534,300 | |||
Total vesting amount |
$ |
1,068,600 |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
At March 31, 2022 |
At December 31, 2021 |
|||||||
Share price |
$ | 10.00 | $ | 10.00 | ||||
Strike price |
$ | 11.50 | $ | 11.50 | ||||
Term (in years) |
5.00 | 5.00 | ||||||
Volatility |
6.0 | % | 10.0 | % | ||||
Risk-free rate |
2.54 | % | 1.47 | % | ||||
Dividend yield |
0.0 | % | 0.0 | % |
Private Warrants (Level 3) |
Public Warrants (Level 1) |
Warrant Liabilities |
||||||||||
Fair value as of December 31, 2021 |
$ |
2,210,000 |
$ |
3,400,000 |
$ |
5,610,000 |
||||||
Change in fair value |
(1,170,000 |
) |
(1,800,000 |
) |
(2,970,000 |
) | ||||||
|
|
|
|
|
|
|||||||
Fair value as of March 31, 2022 |
$ |
1,040,000 |
$ |
1,600,000 |
$ |
2,640,000 |
||||||
|
|
|
|
|
|
At March 31, 2022 |
At February 28, 2022 |
|||||||
Term (years) |
1.25 |
1.33 |
||||||
Selected Debt Yield Rate (B and BB rated bond yields) |
6.0 |
% |
6.0 |
% | ||||
Stock price |
$ |
9.78 |
$ |
9.73 |
||||
Strike price |
$ |
11.50 |
$ |
11.50 |
||||
Volatility |
4.35 |
% |
6.81 |
% | ||||
Risk-free rate |
2.41 |
% |
1.76 |
% | ||||
Dividend yield |
0.0 |
% |
0.0 |
% |
Level 3 |
||||
Issuance of working capital loan at February 28, 2022 |
$ |
275,000 |
||
Initial measurement of draw on working capital loan—related party on February 28, 2022 |
(20,000 |
) | ||
Change in fair value of working capital loan at March 31, 2022 |
1,000 |
|||
|
|
|||
Fair value at March 31, 2022 |
$ |
256,000 |
||
|
|
* | Filed herewith. |
** | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
TB SA ACQUISITION CORP |
/s/ Andrew Rolfe |
Name: Andrew Rolfe |
Title: Chief Executive Officer |
(Principal Executive Officer) |
/s/ James Crawley |
Name: James Crawley |
Title: Chief Financial Officer |
(Principal Financial and |
Accounting Officer) |
1 Year TB SA Acquisition Chart |
1 Month TB SA Acquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions